Alex Nikitine
Dr. iur., LL.M., Attorney at Law
Partner

Alex Nikitine Alex Nikitine Alex Nikitine Alex Nikitine


Alex Nikitine's practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 10 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers Global, Chambers Europe and by IFLR1000 as a leading lawyer in Corporate/M&A, by Legal 500 in Capital Markets. He is considered "knowledgeable and quick" and "very active and likeable" (The Legal 500; Chambers Global).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 43 Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

Contact
Alex Nikitine
Direct phone: +41 58 658 56 32


Walder Wyss Ltd.
Seefeldstrasse 123
P.O. Box
8034 Zurich
Switzerland
Phone +41 58 658 58 58
Fax +41 58 658 59 59
vCard


Practice Areas


 
 
 

Alex Nikitine Alex Nikitine Alex Nikitine Alex Nikitine

Alex Nikitine
Dr. iur., LL.M., Attorney at Law
Partner

Alex Nikitine's practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 10 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers Global, Chambers Europe and by IFLR1000 as a leading lawyer in Corporate/M&A, by Legal 500 in Capital Markets. He is considered "knowledgeable and quick" and "very active and likeable" (The Legal 500; Chambers Global).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 43 Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

 
 
 

Alex Nikitine
Direct phone: +41 58 658 56 32

Walder Wyss Ltd.
Seefeldstrasse 123
P.O. Box
8034 Zurich
Switzerland
Phone +41 58 658 58 58
Fax +41 58 658 59 59


vCard

Practice Areas Publications


Kommentar zum Finanzmarktinfrastrukturgesetz (FinfraG) (Commentary on the Financial Market Infrastructure Act (FMIA))

by Alex Nikitine and Sarah Schulthess
in: Sethe/Favre/Hess/Kramer/Schott (Editor[s]), "Kommentierung zu Art. 137–141 FinfraG (zum Übernahmerecht)"
Zurich 2017, pp. 1888–1935


Management Buy-out - Vorvertragliche Aufklärungspflichten der Manager (Management Buy-out - Pre-Contractual Disclosure Obligations of the Managers )

by Alex Nikitine
in: Rudolf Tschäni (Editor[s]), "Mergers & Acquisitions XVIII"
Zurich / Basel / Geneva 2016, pp. 239-277 (Sonderdruck aus Europa Institut Zürich, Band 169)





Kommentar zu Artikel 8-11, 30 VegüV(Commentary on articles 8-11, 30 VegüV)

by Alex Nikitine
in: Watter/Vogt (Editor[s]), "Basler Kommentar, Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften"
Basel 2015







Der unabhängige Stimmrechtsvertreter in der Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (VegüV): Überblick – herausgegriffene Fragen – Lösungsansätze(The independent shareholders' representative (unabhängiger Stimmrechtsvertreter) under the ordinance against excessive compensations at publicly listed corporations («VegüV»): Overview – Select Issues – Approach)

by Alex Nikitine
in: "Schweizerische Zeitschrift für Wirtschafts- und Finanzmarktrecht (SZW)" 5/2013, pp. 351–366










Use of Share Purchase Agreements in European Jurisdictions: Switzerland

co-authored by Micha Fankhauser and Alex Nikitine
in: Jaletzke/Henle/Beck (Editor[s]), "M&A Agreements in Germany"
Munich 2011, pp. 348–359




Die aktienrechtliche Organverantwortlichkeit nach Art. 754 Abs. 1 OR als Folge unternehmerischer Fehlentscheide: Konzeption und Ausgestaltung der «Business Judgment Rule» im Gefüge der Corporate Governance(The liability of the Board of Directors and Managers under Article 754 para. 1 CO for business judgements: Concept and structure of the business judgement rule in the Corporate Governance context)

by Alex Nikitine
Zurich 2007 (Dissertation)


Golden Handshakes, Golden Parachutes und ähnliche Vereinbarungen bei M&A-Transaktionen(Golden Handshakes, Golden Parachutes and similar arrangements in M&A transactions)

co-authored by Alex Nikitine
in: Rudolf Tschäni (Editor[s]), "Mergers & Acquisitions IX"
Zurich 2007 (Sonderdruck aus Europa Institut Zürich, Band 79)


Deals and Cases

AMEOS Group acquires Swiss Hospital Seeklinik Brunnen

On 8 September 2017, the AMEOS Group acquired the Seeklinik Brunnen.

The Seeklinik Brunnen focuses on integrative medicine and specialises in the treatment of psychological disorders such as burnout, depression and sleep disorders. The clinic has 46 rooms and one of the most modern sleep laboratory in Switzerland.

Covering 41 locations in Germany, Austria and Switzerland, AMEOS Group has 12,800 employees working in 77 health care facilities. AMEOS Group is one of the most important health care providers in the German-speaking countries.

Walder Wyss AG advised AMEOS on all legal aspects of this transaction. The team has been led by Alex Nikitine (Partner, Corporate/M&A) and further included Fabian Glässer (Associate, Corporate/M&A), Francis Nordmann (Partner, Real Estate), André Kuhn (Associate, Real Estate), Daniel Staffelbach (Partner, Regulatory/Health Care) and Christoph Stutz (Associate, Labor law)


Walder Wyss advises Evolute Group AG on its CHF 6 mio. A Round

Walder Wyss advises Evolute Group AG, Zug, on its Series A financing round. The financing round amounts to CHF 6 mio. and was subscribed by investors from the financial and start-up sector.

Evolute Group AG is one of the largest and fastest growing providers of comprehensive technology and platform solutions for wealth and asset management in Switzerland. As a partner for banks, asset managers with and without collective investments and family offices, Evolute Group AG offers comprehensive software solutions, compliance, legal, and risk management, as well as data operations.

The Walder Wyss team consisted of Roger Ammann (Associate, Finance), Alex Nikitine (Partner, Corporate), Janine Corti (Counsel, Tax), Sarah Schulthess (Associate, Corporate) and Fabian D. Glässer (Associate, Corporate).


Auris Medical's Public Equity Offering

Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.

Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The shares of Auris Medical trade on the NASDAQ Global Market.

Walder Wyss advises Auris Medical on Swiss law aspects of the transaction. The team is being led by Alex Nikitine (Partner, Capital Markets, Corporate/M&A) and further includes Sarah Schulthess (Associate, Capital Markets, Corporate/M&A), Janine Corti (Counsel, Tax) and Ayesha Curmally (Partner, Notary).


Cembra Money Bank acquires invoice financing provider SWISSBILLING SA

Cembra Money Bank has reached an agreement to acquire 100% of the shares of SWISSBILLING. The transaction is expected to close within the first quarter of 2017. The transaction consideration was below CHF 10 million and is expected to have a negative impact of 0.1% on the Group’s CET1 ratio as at closing.

Walder Wyss advises Cembra Money Bank on this transaction. The Walder Wyss team includes Markus Pfenninger (Lead Partner, Banking Finance), Alex Nikitine (Partner Capital Markets/Corporate M&A), Fabian D. Glässer (Associate, Banking Finance) und Christoph Stutz (Associate, Corporate/Employment).


Zug Estates CHF 100 mio. Bond

Zug Estates Holding AG (SIX: ZUGN) has successfully issued its first CHF 100 mio. fixed-interest bond with a 0.7% coupon and a 5-year maturity.

Walder Wyss acts as legal counsel to Zug Estates on this capital market transaction. The Walder Wyss Team is being led by Alex Nikitine (Partner, Capital Markets, M&A) and further includes Sarah Schulthess (Associate, Capital Markets, M&A) and Janine Corti (Counsel, Tax).

 


Curriculum Vitae PDF